SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:gup.ub.gu.se/294818"
 

Sökning: id:"swepub:oai:gup.ub.gu.se/294818" > Interplay Between t...

Interplay Between the IL-33/ST2 Axis and Bone Marrow ILC2s in Protease Allergen-Induced IL-5-Dependent Eosinophilia

Boberg, Emma (författare)
Gothenburg University,Göteborgs universitet,Krefting Research Centre
Johansson, Kristina (författare)
Gothenburg University,Göteborgs universitet,Krefting Research Centre
Malmhäll, Carina, 1959 (författare)
Gothenburg University,Göteborgs universitet,Krefting Research Centre
visa fler...
Calvén, Jenny (författare)
Gothenburg University,Göteborgs universitet,Krefting Research Centre
Weidner, Julie, 1983 (författare)
Gothenburg University,Göteborgs universitet,Krefting Research Centre
Rådinger, Madeleine, 1967 (författare)
Gothenburg University,Göteborgs universitet,Krefting Research Centre
visa färre...
 (creator_code:org_t)
2020-06-02
2020
Engelska.
Ingår i: Frontiers in Immunology. - : Frontiers Media SA. - 1664-3224. ; 11
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background:Eosinophils develop from CD34(+)progenitor cells in the bone marrow under the influence of interleukin (IL)-5. Several cell types produce IL-5, including type 2 innate lymphoid cells (ILC2s). The alarmin cytokine IL-33 is known to activate ILC2s in mucosal tissues, but little is known about IL-33-responsive ILC2s in the bone marrow in allergen-induced airway inflammation. Methods:Wild type (WT) and Rag1 deficient (Rag1(-/-)) mice, which lack mature T and B cells, received intranasal doses of papain to induce acute allergic inflammation. In some experiments, mice were pre-treated with anti-IL-5 prior to the papain challenge. Furthermore, recombinant IL-33 was administered to WT mice,Rag1(-/-)mice, lymphocyte deficient mice (Rag2(-/-)Il2rg(-/-)) and toex vivowhole bone marrow cultures. Bone marrow eosinophils and ILC2s were analyzed by flow cytometry. Eosinophil count was assessed by differential cell count and secreted IL-5 from bone marrow cells by ELISA. Results:Intranasal administration of papain or IL-33 increased the number of mature eosinophils in the bone marrow despite the absence of adaptive immune cells inRag1(-/-)mice. In parallel, an increased number of eosinophils was observed in the airways together with elevated levels of Eotaxin-2/CCL24. Bone marrow ILC2s were increased after papain or IL-33 administration, whereas ILC2s was found to be increased at baseline inRag1(-/-)mice compared to WT mice. An upregulation of the IL-33 receptor (ST2) expression on bone marrow ILC2s was observed after papain challenge in bothRag1(-/-)and WT mice which correlated to increased number of bone marrow eosinophilia. Furthermore, an increased number of ST2(+)mature eosinophils in the bone marrow was observed after papain challenge, which was further dependent on IL-5. In addition, bone marrow-derived ILC2s from both mouse strains produced large amounts of IL-5ex vivoafter IL-33 stimulation of whole bone marrow cultures. In contrast, IL-33-induced bone marrow and airway eosinophilia were abolished in the absence of ILC2s inRag2(-/-)Il2rg(-/-)mice and no production of IL-5 was detected in IL-33-stimulated bone marrow cultures. Conclusion:These findings establish bone marrow ILC2s and the IL-33/ST2 axis as promising targets for modulation of uncontrolled IL-5-dependent eosinophilic diseases including asthma.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Immunologi inom det medicinska området (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Immunology in the medical area (hsv//eng)

Nyckelord

allergy
papain
bone marrow
eosinophilia
interleukin-33
interleukin-5
ILC2
asthma
innate lymphoid-cells
interleukin-5 expression
induced increases
murine model
asthma
il-5
lung
association
lymphocytes
progenitors
Immunology

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy